Zydus Lifesciences Launches PEPAIR, India’s First Affordable OPEP Device for COPD, Asthma and Bronchiectasis Patients

Drug-Free Handheld Device Aims to Improve Mucus Clearance and Breathing Support​

New Delhi, February 17: Zydus Lifesciences on Tuesday announced the launch of PEPAIR, an affordable Oscillating Positive Expiratory Pressure OPEP device designed to help patients manage chronic respiratory conditions such as COPD, asthma, and bronchiectasis.

The company stated that PEPAIR is India’s first affordable OPEP device and is intended to support effective mucus clearance, reduce congestion, and improve breathing outcomes for patients dealing with chronic lung disorders.

Addressing a Growing Respiratory Health Burden in India​

According to the company, more than 90 lakh patients in India suffer from chronic respiratory conditions. A significant number of these individuals experience chronic mucous hypersecretion, a condition that requires consistent airway clearance as part of daily care.

Zydus Lifesciences highlighted that PEPAIR has been developed to provide a practical, drug-free solution for managing such symptoms. The handheld, translucent device works by generating controlled pressure and vibrations during exhalation. This oscillating pressure helps loosen mucus, keep airways open, and promote effective clearance from the lungs.

Collaboration with AeroDel Technology Innovations​

PEPAIR is being launched in collaboration with AeroDel Technology Innovations, an Indian medical device company focused on simplifying inhalation through drug delivery and pulmonary rehabilitation technologies.

Sharvil Patel, Managing Director of Zydus Lifesciences, said the company is introducing a drug-free, handheld solution aimed at supporting better breathing for patients with COPD, asthma, and bronchiectasis.

Rising Respiratory Diseases Amid Environmental Challenges​

Zydus Lifesciences noted that respiratory diseases are rising sharply in India. The increase is linked to persistent air pollution, climate-driven changes in allergens and ozone levels, rapid urbanization, and delayed diagnosis of chronic lung conditions.

With PEPAIR, the company seeks to address the growing need for accessible and everyday airway clearance solutions for patients managing long-term respiratory disorders.